Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.

Woo, Jong Shin

Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study. [electronic resource] - Arteriosclerosis, thrombosis, and vascular biology Sep 2013 - 2252-60 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1524-4636

10.1161/ATVBAHA.113.301586 doi


Aged
Biomarkers--blood
Cardiotonic Agents--administration & dosage
Chi-Square Distribution
Creatine Kinase, MB Form--blood
Drug Administration Schedule
Echocardiography, Doppler
Exenatide
Female
Humans
Hypoglycemic Agents--administration & dosage
Injections, Subcutaneous
Magnetic Resonance Imaging
Male
Middle Aged
Myocardial Contraction--drug effects
Myocardial Infarction--blood
Myocardium--enzymology
Peptides--administration & dosage
Percutaneous Coronary Intervention--adverse effects
Predictive Value of Tests
Proportional Hazards Models
Prospective Studies
Republic of Korea
Stroke Volume--drug effects
Time Factors
Treatment Outcome
Troponin I--blood
Venoms--administration & dosage
Ventricular Function, Left--drug effects